市场调查报告书

流感诊断的全球市场:按测试类型(常规诊断(RIDT,直接萤光抗体,病毒培养物,血清),分子诊断(RT-PCR,INAAT(NASBA,LAMP))),最终用户(医院,测试)房间,教育机构等)(至2027年)

Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, & Others)-Global Forecast to 2027

出版商 Meticulous Market Research Pvt. Ltd. 商品编码 942393
出版日期 内容资讯 英文 169 Pages
订单完成后即时交付
价格
流感诊断的全球市场:按测试类型(常规诊断(RIDT,直接萤光抗体,病毒培养物,血清),分子诊断(RT-PCR,INAAT(NASBA,LAMP))),最终用户(医院,测试)房间,教育机构等)(至2027年) Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, & Others)-Global Forecast to 2027
出版日期: 2020年06月15日内容资讯: 英文 169 Pages
简介

全球流感诊断市场预计在2019年至2027年之间的复合年增长率为7.9%,到2027年将达到11.7亿美元。市场增长的主要驱动力包括流行性感冒的流行,对早期发现的认识的提高,免CLIA的POC分子流感检测的发展,重点从集中实验室转移到分散点等。此外,新兴市场(如印度,巴西和中国)为世界各地的供应商提供了巨大的增长机会。

该报告分析了全球感染控制市场,并按产品/解决方案分析了市场的基本结构,主要驱动因素/抑制剂,总体市场趋势展望(过去2年/接下来7年)。我们正在调查按最终用户和地区划分的详细趋势,最近的市场竞争和资本交易的动向以及主要公司的概况。

第1章简介

第2章调查方法

第3章执行摘要

第4章市场考虑

  • 简介
  • 市场促进因素
    • 流感大流行增加
    • 提高对流感早期诊断的认识
    • 开发CLIA免除POC分子流感检测
    • 检查服务:从实验室集中式转变为PoC方法
  • 市场约束因素
    • 中到高复杂度测试的技术要求和监管流程
  • 市场机会
    • 基因组学和蛋白□□质组学的进展
    • 新兴国家的增长机会
  • 挑战
    • 不利和不足的偿还方案
  • 新冠状病毒感染的效果(Covid-19)

按测试类型划分的第五章全球流感诊断市场

  • 简介
  • 常规诊断测试
    • 流感快速诊断检测(RIDT)
    • 直接萤光抗体(DFA)测试
    • 病毒培养
    • 血清测定
  • 分子诊断测试
    • 逆转录聚合□链反应(RT-PCR)
    • 等温核酸扩增试验(INAAT)
    • 其他分子诊断测试

第6章按最终用户划分的全球流感诊断市场

  • 简介
  • 医院和临床实验室
  • 诊断/参考实验室
  • 教育和研究机构
  • 其他最终用户

第7章按地区分列的全球流感诊断市场

  • 简介
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 其他亚太国家
  • 拉丁美洲
  • 中东/非洲

第8章竞争环境

  • 简介
  • 主要增长策略
  • 公司之间的比较分析
  • 市场份额分析(2019)
      F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • Thermo Fisher Scientific,Inc.
    • 阿博特实验室
    • 其他公司

第9章公司简介(业务概览,主要财务指标,产品组合,战略发展状况)

  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Hologic, Inc.
  • Siemens Healthineers AG (Siemens AG?子会社)
  • Luminex Corporation
  • GenMark Diagnostics, Inc.
  • Altona Diagnostics GmbH
  • SA Scientific, Ltd.
  • Sekisui Diagnostics, LLC
  • CorisBioconcept SPRL
  • ELITech Group
  • Mast Group, Ltd.
  • Response Biomedical Corporation
  • Germaine Laboratories, Inc.

第10章附录

目录

Title:
Influenza Diagnostics
by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes)-Global Forecast to 2027.

The influenza diagnostics market is expected to grow at a CAGR of 7.9% from 2020 to 2027 to reach $1.17 billion by 2027.

The growth in the influenza diagnostics market is mainly attributed to the factors such as increasing prevalence of influenza, growing awareness for early detection using specific diagnostic tests, development of CLIA-waived POC molecular influenza tests, and shifting focus from centralized laboratories to decentralized point-of-care testing. In addition, advances in genomics and proteomics and emerging markets such as India, Brazil, China, and other countries provide significant growth opportunities for vendors present across the globe.

To provide efficient analysis, Meticulous Research® has segmented this market by test type (traditional diagnostic tests, molecular diagnostic tests), end user (hospital & clinical laboratories, diagnostic reference laboratories, academic/research institutes, and others), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

Based on test type, the traditional diagnostic tests segment is estimated to account for the largest share of the overall influenza diagnostics market in 2020. The large share of this segment is primarily attributed to the wide use of rapid influenza diagnostics tests (RIDTs) due to its cost-effectiveness and ability to provide test results in 15- 30 minutes. In addition, the availability of advanced diagnostic immunoassay formats and increasing usage of miniaturized devices in influenza diagnostics are further stimulating the growth of this segment. However, the molecular diagnostic tests segment is expected to grow at the fastest growth rate during the forecast period.

Based on end user, the diagnostic reference laboratories segment is projected to register the fastest CAGR during the forecast period, mainly due to their nature of supporting the diagnosis required in patient care as well as medical research. Moreover, owing to curtailed reimbursements for laboratory testing services, hospitals prefer to outsource their diagnostic testing services to the large commercial laboratories and eliminate associated operational expenses required for maintaining in-house labs, thereby driving the market.

An in-depth analysis of the geographic scenario of the influenza diagnostics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America region is estimated to dominate the global influenza diagnostics market in 2020, followed by Europe, and Asia Pacific. The factors such as increasing incidence of influenza, higher adoption for technologically advanced diagnostic products, and increase in the research and development activities for influenza supported the largest share of the North America region in the influenza diagnostics market.

The key players operating in the global influenza diagnostics market are Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Quidel Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Meridian Bioscience Inc. (U.S.),bioMerieux SA (France), Luminex Corporation (U.S.), Siemens Healthineers AG (Germany), GenMark Diagnostics, Inc. (U.S.), Sekisui Diagnostics, LLC (U.S.), altona Diagnostics GmbH (Germany), SA Scientific, Ltd. (U.S.), and ELITech Group (France), Coris Bioconcept SPRL (Belgium), and Mast Group Ltd.(U.K.), among others.

Scope of the Report:

Market by Test Type

  • Traditional Diagnostic Tests
    • Rapid influenza diagnostic tests (RIDTs
    • Direct Fluorescent Antibody (DFA) Tests
    • Viral Culture
    • Serological Assays
  • Molecular Diagnostic Tests
    • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • Isothermal Nucleic Acid Amplification Tests (INAAT)
    • Loop Mediated Isothermal Based Amplification Assays
    • Transcription Mediated Isothermal Based Amplification Assays
    • Transcription Mediated Isothermal Based Amplification Assays
    • Other Isothermal Nucleic Acid Amplification Tests
    • Other Molecular Diagnostic Tests

Market by End User

  • Hospitals & Clinical Laboratories
  • Diagnostic Reference Laboratories
  • Academic/Research Institutes
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Global Prevalence of Influenza
    • 4.2.2. Growing Awareness of Early Influenza Diagnosis
    • 4.2.3. Development of CLIA-Waived POC Molecular Influenza Tests
    • 4.2.4. Shift in Focus from Centralized Laboratories to Point-of-Care Testing Services
  • 4.3. Restraints
    • 4.3.1. Technical Requirements and Regulatory Process for High or Moderate Complexity Tests
  • 4.4. Opportunities
    • 4.4.1. Advances in Genomics and Proteomics
    • 4.4.2. Growth Opportunities in Emerging Economies
  • 4.5. Challenges
    • 4.5.1. Unfavorable and Inadequate Reimbursement Scenario
  • 4.6. Impact of Covid-19 Pandemic

5. Global Influenza Diagnostics Market, by Test Type

  • 5.1. Introduction
  • 5.2. Traditional Diagnostic Tests
    • 5.2.1. Rapid Influenza Diagnostics Test (RIDT)
    • 5.2.2. Direct Fluorescent Antibody (DFA) Tests
    • 5.2.3. Viral Culture
    • 5.2.4. Serological Assays
  • 5.3. Molecular Diagnostic Tests
    • 5.3.1. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • 5.3.2. Isothermal Nucleic Acid Amplification Tests (INAAT)
      • 5.3.2.1. Loop Mediated Isothermal Based Amplification Assays
      • 5.3.2.2. Transcription Mediated Isothermal Based Amplification Assays
      • 5.3.2.3. Nucleic Acid Sequence-Based Amplification Tests
      • 5.3.2.4. Other Isothermal Nucleic Acid Amplification Assays
    • 5.3.3. Other Molecular Diagnostic Tests

6. Global Influenza Diagnostics Market, by End User

  • 6.1. Introduction
  • 6.2. Hospital & Clinical Laboratories
  • 6.3. Diagnostic Reference Laboratories
  • 6.4. Academic/Research Institutes
  • 6.5. Other End Users

7. Global Influenza Diagnostics Market, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Rest of Europe
  • 7.4. Asia-Pacific
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. India
    • 7.4.4. Rest of Asia-Pacific
  • 7.5. Latin America
  • 7.6. Middle East & Africa

8. Competitive Landscape

  • 8.1. Introduction
  • 8.2. Key Growth Strategies
  • 8.3. Competitive Benchmarking
  • 8.4. Market Share Analysis (2019)
    • 8.4.1. F. Hoffmann-La Roche Ltd
    • 8.4.2. Quidel Corporation
    • 8.4.3. Thermo Fisher Scientific, Inc.
    • 8.4.4. Abbott Laboratories
    • 8.4.5. Other Companies

9. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)

  • 9.1. Thermo Fisher Scientific, Inc.
  • 9.2. Abbott Laboratories
  • 9.3. Danaher Corporation
  • 9.4. Bio-Rad Laboratories, Inc.
  • 9.5. BioMerieux S.A.
  • 9.6. F. Hoffmann-La Roche Ltd.
  • 9.7. Becton, Dickinson and Company
  • 9.8. Meridian Bioscience, Inc.
  • 9.9. Quidel Corporation
  • 9.10. Hologic, Inc.
  • 9.11. Siemens Healthineers AG (Subsidiary of Siemens AG)
  • 9.12. Luminex Corporation
  • 9.13. GenMark Diagnostics, Inc.
  • 9.14. Altona Diagnostics GmbH
  • 9.15. SA Scientific, Ltd.
  • 9.16. Sekisui Diagnostics, LLC
  • 9.17. CorisBioconcept SPRL
  • 9.18. ELITech Group
  • 9.19. Mast Group, Ltd.
  • 9.20. Response Biomedical Corporation
  • 9.21. Germaine Laboratories, Inc.

10. Appendix

  • 10.1. Questionnaire
  • 10.2. Available Customization

List of Tables

  • Table 1 Global Influenza Diagnostics Market Drivers: Impact Analysis (2020-2027)
  • Table 2 Europe: Percentage of Specimens Positive for Influenza, 2015-2020
  • Table 3 Global Influenza Diagnostics Market Restraint: Impact Analysis (2020-2027)
  • Table 4 Some Clinical Applications of Influenza Genomics and Proteomics
  • Table 5 COVID 19 Confirmed Cases and Deaths across the World (27th May 2020)
  • Table 6 Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($ Million)
  • Table 7 Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 8 Traditional Influenza Diagnostic Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 9 Advantages & Disadvantages of RIDT
  • Table 10 RIDTs Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 11 Direct Fluorescent Antibody Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 12 Viral Culture Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 13 Serological Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 14 Molecular Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 15 Molecular Influenza Diagnostic Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 16 Comparison of RT-PCR with Traditional Diagnostic Tests
  • Table 17 RT-PCR Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 18 INAAT Based Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 19 INAAT Based Influenza Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 20 Loop-Mediated Isothermal Amplification (Lamp) Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 21 Transcription Mediated Isothermal Based Amplification Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 22 Nucleic Acid Sequence-Based Amplification Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 23 Other INAAT Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 24 Other Molecular Influenza Diagnostic Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 25 Influenza Diagnostics Market Size, by End User, 2018-2027 ($ Million)
  • Table 26 Influenza Diagnostics Market Size for Hospital & Clinical Laboratories, by Country/Region, 2018-2027 ($ Million)
  • Table 27 Influenza Diagnostics Market Size for Diagnostic Reference Laboratories, by Country/Region, 2018-2027 ($Million)
  • Table 28 Influenza Diagnostics Market Size for Academics/Research Institutes, by Country/Region, 2018-2027 ($Million)
  • Table 29 Influenza Diagnostics Market Size for Other End Users, by Country/Region, 2018-2027 ($Million)
  • Table 30 Influenza Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 31 North America: Influenza Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 32 North America: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 33 North America: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 34 North America: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 35 North America: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 36 North America: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 37 U.S.: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 38 U.S.: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 39 U.S.: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 40 U.S.: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 41 U.S.: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 42 Canada: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 43 Canada: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 44 Canada: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 45 Canada: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 46 Canada: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 47 Europe: Influenza Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 48 Europe: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 49 Europe: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 50 Europe: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 51 Europe: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 52 Europe: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 53 Germany: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 54 Germany: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 55 Germany: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 56 Germany: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 57 Germany: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 58 France: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 59 France: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 60 France: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 61 France: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 62 France: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 63 Number of Acute Respiratory Illness Outbreaks in the U.K. by Institution Type: 2015-2019
  • Table 64 U.K.: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 65 U.K.: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 66 U.K.: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 67 U.K.: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 68 U.K.: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 69 Italy: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 70 Italy: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 71 Italy: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 72 Italy: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 73 Italy: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 74 Spain: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 75 Spain: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 76 Spain: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 77 Spain: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 78 Spain: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 79 Rest of Europe: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 80 Rest of Europe: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 81 Rest of Europe: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 82 Rest of Europe: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 83 Rest of Europe: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 84 Asia-Pacific: Influenza Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 85 Asia-Pacific: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 87 Asia-Pacific: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 88 Asia-Pacific: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 89 Asia-Pacific: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 90 China: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 91 China: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 92 China: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 93 China: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 94 China: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 95 Japan: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 96 Japan: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 97 Japan: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 98 Japan: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 99 Japan: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 100 India: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 101 India: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 102 India: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 103 India: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 104 India: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 105 Rest of Asia-Pacific: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 106 Rest of Asia-Pacific: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 107 Rest of Asia-Pacific: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 108 Rest of Asia-Pacific: Isothermal Nucleic Acid Amplification Tests Market Size, 2018-2027 ($Million)
  • Table 109 Rest of Asia-Pacific: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 110 Latin America: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 111 Latin America: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 112 Latin America: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 113 Latin America: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 114 Latin America: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 115 Middle East & Africa: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 116 Middle East & Africa: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 117 Middle East & Africa: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 118 Middle East & Africa: Isothermal Nucleic Acid Amplification Tests Market Size, 2018-2027 ($Million)
  • Table 119 Middle East & Africa: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 120 Recent Developments, by Company, 2017-2020

List of Figures

  • Figure 1 Key Stakeholders
  • Figure 2 Research Process
  • Figure 3 Key Secondary Sources
  • Figure 4 Primary Research Techniques
  • Figure 5 Key Executives Interviewed
  • Figure 6 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 7 Market Size Estimation
  • Figure 8 Global Influenza Diagnostics Market, by Test Type, 2020 Vs 2027 ($Million)
  • Figure 9 Global Influenza Diagnostics Market Overview, by End User, 2020-2027 ($Million)
  • Figure 10 Regional Snapshot: Influenza Diagnostics Market
  • Figure 11 Market Dynamics
  • Figure 12 Global Influenza Transmission Zone
  • Figure 13 U.S. Influenza Burden (2010-2018)
  • Figure 14 Global Influenza Diagnostics Market Size, by Test Type, 2020-2027 ($Million)
  • Figure 15 Global Influenza Diagnostics Market Size, by End User, 2020-2027 ($Million)
  • Figure 16 Global Influenza Diagnostics Market Size, by Geography, 2020-2027 ($Million)
  • Figure 17 North America: Influenza Diagnostics Market Snapshot
  • Figure 18 Population Aged 65 or above (As % of total Population) in the U.S.:2012-2018
  • Figure 19 Europe: Influenza Diagnostics Market Snapshot
  • Figure 20 Healthcare Spending Per Capita in France: 2015-2018
  • Figure 21 Proportion of Population Aged 65 or Above (As % of total Population)
  • Figure 22 Influenza Cases in Spain per 100,000 Inhabitants: 2015-2019
  • Figure 23 Per Capita Health Spending by Country, 2018 ($)
  • Figure 24 Asia-Pacific: Influenza Diagnostics Snapshot
  • Figure 25 Number of Geriatric Population (Aged 65 & Above) In China: 2010-2050(In Millions)
  • Figure 26 Number of Swine Flu Cases in India: 2012-2018
  • Figure 27 Population Aged 60 & Above In Latin America: 2000-2050 (In Millions)
  • Figure 28 Key Growth Strategies Adopted by Leading Players, 2017-2020
  • Figure 29 Influenza Diagnostics Market: Competitive Benchmarking
  • Figure 30 Global Influenza Diagnostics Market Share Analysis, by Key Players, 2019 (%)
  • Figure 31 thermo Fisher Scientific, Inc.: Financial Overview (2019)
  • Figure 32 Abbott Laboratories: Financial Overview (2019)
  • Figure 33 Danaher Corporation: Financial Overview (2019)
  • Figure 34 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
  • Figure 35 BioMerieux S.A.: Financial Overview (2018)
  • Figure 36 F. Hoffmann-La Roche Ltd: Financial Overview (2019)
  • Figure 37 Becton, Dickinson and Company: Financial Overview (2019)
  • Figure 38 Meridian Bioscience, Inc.: Financial Overview (2019)
  • Figure 39 Quidel Corporation: Financial Overview (2019)
  • Figure 40 Hologic, Inc.: Financial Overview (2019)
  • Figure 41 Siemens Healthineers Ag: Financial Overview (2019)
  • Figure 42 Luminex Corporation: Financial Overview (2019)
  • Figure 43 GenMark Diagnostics, Inc.: Financial Overview (2019)